AUPH (Aurinia Pharmaceuticals Inc) Sof foyda

AUPH (Aurinia Pharmaceuticals Inc.) - kompaniyaning tovar belgisi

Aurinia Pharmaceuticals (AUPH) lyupus nefriti uchun FDA tomonidan tasdiqlangan birinchi oral preparatga eksklyuziv huquqlarga ega bo'lib, bu keyingi o'n yilgacha raqobatchi yo'qligini ta'minlaydi. Biznes og'ir autoimmun buyraklar zararlanishlari uchun maqsadli terapiyalarni ishlab chiqishga e'tibor qaratadi. GURU.Markets saytidagi ushbu grafik foyda 0.32 darajasida ekanligini ko'rsatadi, shu bilan birga kompaniya ishlab chiqarish jarayonida standart ekologik qoidalarga va asosiy muvofiqlik talablariga rioya qiladi.

AUPH (Aurinia Pharmaceuticals) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

Aurinia Pharmaceuticals Inc. (AUPH) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Aurinia Corp|AUPH - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Aurinia Corp|AUPH - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Aurinia Pharmaceuticals|AUPH - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi auriniapharma.com|AUPH - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Aurinia Pharmaceuticals|AUPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Aurinia Pharmaceuticals Inc|AUPH - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Aurinia Corp|AUPH - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Aurinia Pharmaceuticals|Shoshilinch likvidlik auriniapharma.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
AUPH - Sof foyda
Kompaniyaning jamlanma tahlili:Aurinia Pharmaceuticals
Aurinia Pharma asosiy tovari

Aurinia Pharmaceuticals (AUPH) uchun foyda intellektual mulkni kapitalizatsiya qilish samaradorligining asosiy ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika umumiy daromaddan barcha operatsion xarajatlar va soliqlarni chegirib tashlagandan keyin qolgan mablag'larni aks ettiradi. GURU.Markets platformasida kompaniyaning yakuniy moliyaviy natijalarini tahlil qilish orqali investor biznesning haqiqiy qiymatini ko'radi. Ushbu tendentsiya ishlab chiqarishni avtomatlashtirish va ekspert klinik sinovlar xarajatlari o'rtasidagi muvozanatni aks ettiradi. Grafik egri chizig'ining ekstremum nuqtalari aktivning bozorda haddan tashqari qimmat baholanganligi yoki past baholanganlik darajasini belgilaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|NKTR - Sof foyda|UPB (Upstream Bio Inc) - Sof daromad|zenasbio.com (ZBIO) - Sof foyda|Kompaniyaning sof foydasi Immunome|GOSS: Yakuniy foyda|Sof foyda KALV|Sof moliyaviy natija Septerna Pharma|Kompaniyaning sof foydasi Pieris Pharmaceuticals PVLA|SVRA: Kompaniya foydasi|Rigel Pharmaceuticals, Inc. - Sof foyda|Sof moliyaviy natija AnaptysBio Inc ANAB|ATXS: Sof foyda|enGene Corp (ENGN) - Sof foyda|Sof daromad RAPT|JBIO: Yakuniy foyda|Kompaniyaning sof foydasi Aclaris Therapeutics, Inc. (ACRS)|KYTX: Soliqdan keyingi foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Yakuniy foyda CABA|Ventyx Biosciences - Sof foyda|THTX - Sof foyda|Avalo Therapeutics (AVTX) - Kompaniyaning sof foydasi|Eledon Pharmaceuticals Inc. - Yakuniy foyda|Kompaniyaning sof foydasi Agenus Inc|Sof daromad Climb Bio, Inc (CLYM)|Sof foyda ZURA|Sof foyda atyrpharma.com (ATYR)|Sof foyda ADAG (Adagene Inc.)|IMA - Sof daromad|Shattuck Therapeutics - Sof foyda|Kompaniyaning sof daromadi Equillium, Inc.|CNTB (connectbiopharm.com) - Sof daromad|Immunic (IMUX) - Sof foyda|Sof daromad ATRA|IFRX (InflaRx GmbH) - Soliqlar to‘langandan keyingi foyda|Sof foyda XFOR|Sof moliyaviy natija adicetbio.com|Sof foyda CELU (Celularity)|INMB - Sof daromad|Barinthus Biotherapeutics plc - Sof foyda|KZR - Sof foyda|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|AKTX (Akari Therapeutics, Plc) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Sof moliyaviy natija|Sof foyda GOVX|Sof foyda Edesa Biotech Inc (EDSA)|iBio Corp - Sof daromad|Sof foyda Carisma Therapeutics Inc CARM|XTLB - Kompaniyaning sof foydasi|Soliqdan keyingi foyda BOLT|HCWB: Sof foyda|Aptevo Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Aditxt Corp - Soliqdan keyingi foyda|Sof foyda GRI|XRTX (xortx.com) - Yakuniy foyda|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|INDP - Kompaniyaning sof foydasi|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|ALLK (Allakos Inc) - Sof foyda|Sof foyda HOOKIPA|Sof daromad IGMS (IGM Biosciences, Inc.)|ITOS (iTeos Pharma) - Yakuniy foyda|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof moliyaviy natija tcbiopharm.com (TCBP)|THRD - Kompaniyaning sof foydasi